< Back to previous page
Project
BioGelator for local immunotherapy (BioBoost)
Local administration of immunotherapeutics is burdened by low bio-availability. BioBoost is a technical solution that facilitates the interaction between these compounds and the immune cells of interest. In this way, BioBoost can be commercialized as a complementary technology for companies with a pipeline of novel immunotherapeutics.
Date:15 Jul 2021 → Today
Keywords:excipient, immunotherapy, cancer
Disciplines:Biopharmaceuticals, Biomaterials, Biomaterials engineering not elsewhere classified, Cancer therapy